U.S., Nov 10: Pfizer asked U.S. regulators Tuesday to allow boosters of its COVID-19 vaccine for anyone 18 or older, a step that comes amid concern about increased spread of the coronavirus with holiday travel and gatherings.
WASHINGTON, Nov 6: Pfizer Inc. said that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
NEW YORK, Oct 24: Scientists at the U.S. Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer (PFE.N)/BioNTech COVID-19 vaccine to 5 to 11 year olds clearly outweigh the risks of rare cases of heart inflammation.
June 25: The U.S. drug regulator on Friday added a warning to the literature that accompanies Pfizer Inc (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O) COVID vaccine shots to indicate the rare risk of heart inflammation after its use.
LONDON, Dec 12: The U.S. Food and Drug Administration said it authorized the use of Pfizer Inc’s COVID-19 vaccine on Friday, with the first inoculations expected within days, marking a turning point in the United States where the pandemic has killed more than 295,000 people.